Gardia Medical specializes in the development and commercialization of catheter-based delivery systems that easily integrate with the standard workflow of stenting and other cardiovascular interventional procedures. Gardia Medical's flagship product is the first and only embolic protection device (EPD) to Deliver, Lock, and Deploy on any guide wire, anywhere on the wire. Its compatibility with standard guide wires and easy integration with the workflow of interventional procedures sets a new standard for the cardiovascular intervention field. 

 

EPD’s are known to reduce the incidence of embolic complications during catheter-based procedures such as carotid and SVG angioplasty. Physicians using EPD’s today face a number of challenges, most significantly the need to use specialized guide wires which can be difficult to maneuver, resulting in more complex and lengthy procedures.

 

Gardia Medical’s proprietary technology is designed for use in a variety of applications in the field of interventional medicine. It provides a unique solution for the interventional physician allowing in-situ locking of cardiovascular devices such as EPD's onto a standard guide wire, anywhere along the wire.

 

Gardia Medical’s Embolic Protection System is CE marked.

Gardia Medical is a privately-held company founded in 2006. Uri Rosenschein, interventional cardiologist, co-founded the company with Medica Venture Partners, Israel's oldest and largest healthcare dedicated venture capital fund.